HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon? (Q39699953)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

In Ah Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Il Han Kim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Hak Jae Kim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Jae-Sung Kim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

Journal of Radiation Research

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

257-263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

Histone acetylation in chromatin structure and transcription

3 February 2020

cites work

1 reference

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

21 January 2018

1 reference

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

21 January 2018

1 reference

Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis

21 January 2018

1 reference

Chemical agents that promote chromatin compaction radiosensitize tumour cells

21 January 2018

1 reference

Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4

21 January 2018

1 reference

Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response

21 January 2018

1 reference

Deacetylation of p53 modulates its effect on cell growth and apoptosis

21 January 2018

1 reference

p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

21 January 2018

1 reference

Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1269/JRR.09115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20505264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference